Therapy Adjustment and IndividuaLized Response With Biomarker Observation in ReaL-world Heart Failure
NCT07647848 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2026-06-15
Summary
The goal of TAILOR-HF is to integrate clinical data, laboratory parameters, treatment patterns, and circulating biomarkers to identify factors that predict individual response to pharmacological treatment in patients with heart failure.
TAILOR-HF is an observational study with protocol-mandated assessments scheduled at baseline and at 1, 3, and 6 months after enrolment. Additional follow-up data will be collected through telephone visits every 6 months until the last participant has completed the protocol-mandated 6-month visit.
Conditions
- Chronic Heart Failure
- Acute Decompensated Heart Failure
Sponsors & Collaborators
-
UMCG, University Hospital (Groningen, The Netherlands)
collaborator UNKNOWN -
Leiden University Medical Center
collaborator OTHER - collaborator OTHER
-
Uniklinik RTWH Aachen
collaborator UNKNOWN -
Charite University, Berlin, Germany
collaborator OTHER -
Ospedale San Donato
collaborator OTHER -
Fidenza Hospital
collaborator UNKNOWN -
Desio Hospital
collaborator UNKNOWN -
Gorizia Hospital
collaborator UNKNOWN -
UZ Antwerpen
collaborator UNKNOWN -
Medizinischen Universität Wien
collaborator UNKNOWN -
University College Dublin
collaborator OTHER -
University of Ulster
collaborator OTHER -
University of Glasgow
collaborator OTHER -
Maastricht University Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-09-01
- Primary Completion
- 2028-09-01
- Completion
- 2028-09-01
More Related Trials
-
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
NCT05577819 ·Status: RECRUITING ·Phase: NA
-
The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.
NCT07513883 ·Status: RECRUITING ·Phase: PHASE4
-
Predictors of an Unfavorable Outcome in Patients With Heart Failure
NCT04753814 ·Status: COMPLETED ·Phase: NA
-
Individualized Early Risk Assessment for Heart Diseases
NCT02417311 ·Status: UNKNOWN
-
Tadalafil and Nesiritide as Therapy in Pre-clinical Heart Failure
NCT01544998 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Polypharmacy, Safety, and Medication Adherence in Patients With Chronic Heart Failure With Reduced and Mildly Reduced Ejection Fraction
NCT07640854 ·Status: ACTIVE_NOT_RECRUITING
-
Heart Failure in Norway: Clinical Characteristics, Mortality and Health Care Resource Use
NCT04398563 ·Status: UNKNOWN
-
A Phase II Trial to Assess Hemodynamic Effects of Istaroxime in Pts With Worsening HF and Reduced LV Systolic Function
NCT00616161 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study on the Patient's Ability to Use a Digital Platform in Heart Failure
NCT06869408 ·Status: COMPLETED
-
Follow-up Strategies for Fragile Patients With Decompensated Heart Failure
NCT04643184 ·Status: TERMINATED ·Phase: NA
-
Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets
NCT02522208 ·Status: COMPLETED ·Phase: PHASE1
-
Developing Oral LT3 Therapy for Heart Failure - HFpEF
NCT04111536 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Strategy of Home Telehealth for Management of Congestive Heart Failure(STARTEL)
NCT00247000 ·Status: COMPLETED ·Phase: NA
-
TorasEmide Induced Effect on QoL and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone.
NCT06117722 ·Status: RECRUITING
-
Evaluation of Baroreflex Activation Therapy in Patients With Advanced Heart Failure
NCT03230643 ·Status: COMPLETED
-
Guideline Implementation and Quality of Care in Patients With Heart Failure: the TITRATE-HF Registry
NCT06386042 ·Status: ACTIVE_NOT_RECRUITING
-
Biomarker Guided Therapies in Stage A/B Heart Failure
NCT02230891 ·Status: COMPLETED ·Phase: PHASE2
-
Consultation at 8 Days to Reduce Hospitalisations in Heart Failure Patient
NCT01834833 ·Status: COMPLETED ·Phase: NA
-
Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure (HF) in Germany
NCT06675552 ·Status: ACTIVE_NOT_RECRUITING
-
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
NCT06526988 ·Status: RECRUITING ·Phase: NA
-
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
NCT06979362 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Adult Participants With Heart Failure With Reduced Ejection Fraction
NCT05139615 ·Status: TERMINATED ·Phase: PHASE2
-
Real-world Research : Assessment of Effect of Combination of Drugs in the Treatment of Heart Failure
NCT06158711 ·Status: NOT_YET_RECRUITING
-
1 Year Post Discharge Prognostic Model From the National Heart Failure Audit (NHFA)
NCT02353481 ·Status: UNKNOWN
-
Feasibility of Implementation of Recommended Standards in Patients With Heart Failure
NCT04806048 ·Status: COMPLETED